Oak Point Wealth Management acquired a new stake in Stryker Corporation (NYSE:SYK) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 945 shares of the medical technology company’s stock, valued at approximately $145,000.

A number of other large investors have also recently made changes to their positions in SYK. Acrospire Investment Management LLC bought a new stake in shares of Stryker during the second quarter worth $111,000. Motco grew its stake in shares of Stryker by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the last quarter. San Francisco Sentry Investment Group CA grew its stake in shares of Stryker by 47.8% during the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after buying an additional 325 shares during the last quarter. Bruderman Asset Management LLC bought a new stake in shares of Stryker during the second quarter worth $150,000. Finally, BB&T Investment Services Inc. bought a new stake in shares of Stryker during the second quarter worth $178,000. 74.90% of the stock is currently owned by institutional investors and hedge funds.

A number of analysts have weighed in on SYK shares. SunTrust Banks reaffirmed a “buy” rating and set a $161.00 target price on shares of Stryker in a research note on Monday, October 2nd. Royal Bank of Canada reaffirmed a “buy” rating and set a $155.00 target price on shares of Stryker in a research note on Monday, October 2nd. Cowen set a $160.00 target price on shares of Stryker and gave the stock a “buy” rating in a research note on Friday, October 6th. Zacks Investment Research cut shares of Stryker from a “hold” rating to a “sell” rating in a research note on Monday, October 16th. Finally, Robert W. Baird reaffirmed a “hold” rating and set a $161.00 target price on shares of Stryker in a research note on Friday, October 27th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $156.60.

Shares of Stryker Corporation (NYSE:SYK) opened at $159.54 on Thursday. The company has a quick ratio of 1.61, a current ratio of 2.37 and a debt-to-equity ratio of 0.63. Stryker Corporation has a one year low of $119.17 and a one year high of $164.20. The firm has a market cap of $59,710.00, a price-to-earnings ratio of 34.02, a P/E/G ratio of 2.30 and a beta of 0.78.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.97 billion. During the same quarter in the previous year, the firm posted $1.39 earnings per share. Stryker’s revenue for the quarter was up 6.1% on a year-over-year basis. analysts forecast that Stryker Corporation will post 6.47 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a $0.47 dividend. This is a boost from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. This represents a $1.88 annualized dividend and a dividend yield of 1.18%. Stryker’s payout ratio is currently 40.09%.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the transaction, the insider now owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 7.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/oak-point-wealth-management-acquires-shares-of-945-stryker-corporation-syk/1802529.html.

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.